Document Type : Original Research
Authors
1 Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
2 Department of Cardiac Surgery, Faculty of Medicine, Cairo University, Egypt
3 Department of Pediatrics, Kalyoob Specialized Hospital, Egypt
Abstract
Keywords
Introduction
Major forms of congenital cardiovascular defects are recognized birth defects that occur between 4- 19 per 1000 live births. Surgical repair is often required during infancy. Despite improving mortality, risk of transplant or death in the first year of life remains 10-20% for complex interventions (2, 3). Complications associated with cardiac surgery are related to type of underlying defect, type of surgery and use of cardiopulmonary bypass (CPB) and other risk factors.(4) Complications list is variable and affects variable body systems; cardiovascular, neurologic, hepatic, renal, blood, etc. (5, 6). CPB might be employed to maintain circulation and tissue oxygenation during cardiac surgery (7). CPB is a non-physiologic circulation and the patients are subjected to a various degree of body organ dysfunction. As the number of patients undergoing cardiac surgery is increased; the need for CPB is also increased (8).
Hepatic injury post CPB results from centrilobular sinusoid ischemia, subsequent reperfusion injuries, the systemic inflammatory response syndrome and oxidative stress (7). Other mechanisms include drug induced hepatic injury or systemic inflammatory reaction by CPB (9). Consumption of coagulation factors during CPB and subsequent micro-thrombi formation in centrilobular hepatic sinusoids was also reported to compromise liver function post cardiac surgery (6). On the other hand, others demonstrated that short CPB time of less than two hours was not associated with compromised hepatic functions. Furthermore, an elevation of serum liver transaminases after uncomplicated CPB has also been reported in some studies. Hepatic injury associated with infections, hypo-perfusion and shocked liver is preventable (10).
We aimed to study liver functions and sonographic changes after open heart surgery in pediatric patients with congenital heart diseases between 6- 18months postoperatively.
Subjects and Methods
This analytical cross-sectional study was conducted from September 2017 to July 2018. The study was approved by Higher Research Committee of Faculty of Medicine, Cairo University, Egypt. It was carried out in accordance with the Helsinki declaration (11).
Participants
The study included 50 pediatric patients with congenital heart disease who underwent cardiac surgery. They were assessed 6 months- 18 months postoperatively. They were recruited from Post-cardiac Intervention Clinic, Pediatric Cardiology Unit, Pediatrics Department, Faculty of Medicine, Cairo University. Pediatric patients with other associated congenital anomalies, known associated chronic liver disease, chronic kidney disease presenting prior to surgery were not included in the study.
Methods
Data Collection:
All relevant data were collected related to age, gender, consanguinity, history of similar conditions in family, type of congenital disease and type of repair, medications (type and dose), regularity of follow up, and the presence of complications related to cardiac surgery. All data of clinical examination was also collected.
Lab investigations:
Liver function tests: aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl transpeptidase (GGT), alkaline phosphatase (ALP), albumin, total protein, total and direct bilirubin and coagulation profile: international normalized ratio (INR), prothrombin time (PT) and partial thromboplastin time (PTT) were performed.
Imaging:
Abdominal U/S: images were obtained using Toshiba model Nemio XG probe PVM375AT,3.75 MHZ and another model is Toshiba Xario 100.
Echocardiography: Images were obtained using 3.0-MHz or 5.0-MHz phased-array transducer of the Vivid 5 echocardiographic scanner (GE Ultrasound, Horten, Norway). The choice between transducers depended on the age of the child.
Other investigations that were deemed necessary by clinical judgment suggesting hepatic affection as were performed (viral screening, metabolic screening etc.)
Statistical Analysis
Data were coded, tabulated and analyzed using the statistical package SPSS (Statistical Package for the Social Sciences) version 25. Data were summarized as mean, standard deviation, median, minimum and maximum for quantitative data. For categorical data frequency (count) and relative frequency (percentage) were employed. Statistical tests of significance were used; comparisons between quantitative variables were done using the non-parametric MannWhitney test. For comparing categorical data, Chi square (χ²) test was performed. Exact test was used instead when the expected frequency was less than 5. Correlations between quantitative variables were done using Spearman correlation coefficient. P-values less than 0.05 were considered as statistically significant.
Results
Table 1: Type of Congenital Heart Disease among the studied cohort.
|
Number |
% |
|
Number |
% |
ASD-VSD |
6 |
12 |
PS-VSD |
1 |
2 |
VSD |
3 |
6 |
PDA-ASD |
1 |
2 |
COA |
6 |
12 |
VSD-MS |
1 |
2 |
ASD-PS |
1 |
2 |
VSD-MS-TR |
1 |
2 |
Fallot Tetralogy |
7 |
14 |
VSD-PS |
1 |
2 |
MS |
1 |
2 |
ASD-VSD-MR-TR |
1 |
2 |
TGA |
6 |
12 |
PDA-AR-PFO |
1 |
2 |
CAVC |
7 |
14 |
COA-AS-Bicuspid AV |
1 |
2 |
DORV |
5 |
10 |
|
|
|
AR: aortic regurgitation; ASD: atrial septal defect; AS: aortic stenosis; AV: aortic valve; CAVC: complete atrioventricular canal defect; COA: coarctation of aorta; DORV: Double outlet right ventricle; MS: mitral stenosis; PDA: patent ductus arteriosus; PFO: patent foramen oval; PS: pulmonary stenosis; TGA: transposition of great arteries; TR: tricuspid regurgitation; VSD: ventricular septal defect.
Table 2: Comparison between liver function tests in studied groups.
|
With CPB; n=40 (open heart) |
Without CPB; n=10 (closed heart) |
P value |
||
Mean ±SD |
Range (Min-Max) |
Mean ±SD |
Range (Min-Max) |
||
ALT |
62.07 ±89.6 |
(12.00 - 498.00) |
49.40 ±39.9 |
(12.00 - 122.00) |
0.729 |
AST |
64.67 ±59.2 |
(13.00 - 312.00) |
56.70 ±30.3 |
(34.00 - 138.00) |
0.607 |
GGT |
32.75 ±38.1 |
(15.00 - 150.00) |
15.60 ±6.9 |
(5.00 - 25.00) |
0.356 |
ALP |
258.43 ±120.5 |
(16.00 - 838.00) |
261.70 ±67.2 |
(181.0 - 356.0) |
0.729 |
Albumin |
4.00 ±0.3 |
(3.40-4.50) |
3.98 ±0.5 |
(3.20 - 4.60) |
0.802 |
Total Protein |
7.59 ±1.2 |
(6.40-13.90) |
7.07 ±0.6 |
(6.10 - 8.20) |
0.125 |
Direct Bilirubin |
0.08 ±0.1 |
(0.00 - 0.20) |
0.10 ±0.1 |
(0.00 - 0.20) |
0.395 |
Indirect Bilirubin |
0.35 ±0.2 |
(0.10 - 0.90) |
0.34 ±0.2 |
(0.20 - 0.80) |
0.952 |
PT |
12.73 ±1.2 |
(10.80 - 15.80) |
12.25 ±0.9 |
(11.10 - 14.10) |
0.144 |
INR |
1.06 ±0.1 |
(0.97-1.30) |
1.04 ±0.04 |
(1.00 - 1.10) |
0.465 |
RBS |
98.70 ±10.4 |
(79.00 - 123.00) |
101.50 ±16.3 |
(76.00 -125.00) |
0.607 |
ALT: alanine transaminase; AST: aspartate transaminase; ALP: alkaline phosphatase; GGT: gamma glutamyl transpeptidase; INR: International normalized ratio; PT: Prothrombin Time; RBS: random blood sugar.
Table 3: Distribution of children with HCV among our studied cohort.
|
|
With CPB; n=40 |
Without CPB; n=10 |
||
Count |
% |
Count |
% |
||
HCV |
Yes |
11 |
24.4% |
1 |
20.0% |
Not screened |
34 |
75.6% |
4 |
80.0% |
HCV: hepatitis C virus infection.
Table 4: Comparison between studied groups regarding hepatic and renal sonographic findings.
|
FINDING |
With CPB; n=40 |
Without CPB; n=10 |
P value |
||
Count |
% |
Count |
% |
|||
Liver Size |
Enlarged |
11 |
27.5% |
1 |
10.0% |
0.416 |
Normal |
29 |
72.5% |
9 |
90.0% |
||
Bright Liver |
Yes |
16 |
40.0% |
4 |
40.0% |
>0.999 |
No |
24 |
60.0% |
6 |
60.0% |
||
Dilated Portal Vein |
Dilated |
11 |
27.5% |
2 |
20.0% |
>0.999 |
Normal |
29 |
72.5% |
8 |
80.0% |
||
Prominent Caudate Lobe |
Yes |
9 |
22.5% |
0 |
.0% |
0.174 |
No |
31 |
77.5% |
10 |
100.0% |
||
Congested Liver |
Congested |
9 |
22.5% |
1 |
10.0% |
0.663 |
Normal |
31 |
77.5% |
9 |
90.0% |
||
Splenomegaly |
Yes |
4 |
10.0% |
0 |
.0% |
0.571 |
No |
36 |
90.0% |
10 |
100.0% |
||
Echogenic Kidney |
Yes |
12 |
30.0% |
5 |
50.0% |
0.277 |
No |
28 |
70.0% |
5 |
50.0% |
||
Calcification in kidney |
Yes |
7 |
17.5% |
5 |
50.0% |
0.046* |
No |
33 |
82.5% |
5 |
50.0% |
Discussion
Further studies are needed to verify the incidence of HCV among children with cardiac congenital anomalies and the mode of transmission of HCV. It is important to screen these children as direct antiviral treatment of HCV is approved and available for children 3 years old and above (17). It is important to implement routine screening as these cases are sources of infection to their households as they had a silent clinical picture. This means infection spread rapidly and would go largely unnoticed (18).
The sonographic findings in our study included hepatomegaly in 12 (24%), liver brightness in 60%, dilated portal vein in 26%, congested liver 20% and prominent caudate lobe in 18%. Congestion of liver improved upon change/ increase of drug induced diuresis among our studied cohort. We did not come across the cause of congestion apart from inadequate preload medication use. All children with congested enlarged livers encountered in our study post-operatively were related to insufficient control of systemic congestion following the intervention. Yet, the use of diuretics were found to be associated with renal calcification in 26% of our studied cohort. The fine tuning of dose to achieve control of systemic congestion and renal calcification needs regular follow up and sonographic imaging.
Fifty four percent of our studied cohort with congenital heart diseases were products of consanguineous marriages. Future studies are needed to verify the genetic mutations if any that underlie susceptibility to develop congenital heart diseases among consanguineous couples. Raising more awareness about consanguineous marriage and its effect on congenital abnormalities is a necessity.
Limitations of the study include the inaccessibility to operative data and the lack of screening for hepatic viral infections before and after major cardiac surgery, hence we could not tell whether the infection was related to the procedure or otherwise. Again another limitation was lack of screening of those with normal transaminases for HCV infection as it was not within the scope of this cross-sectional study.
Conclusion
Abnormal liver functions are not uncommon in patients 6-18 months post cardiac surgery. Abnormal liver functions might be related to hepatitis C affection. Open heart surgery may be associated with increased risk of hepatitis C infection. Increased liver brightness is the most common sonographic finding. Pre-cardiac surgery screening for HCV is mandatory in children.
Author Contributions: All authors shared in conceptualization, supervising, data curation, data analysis, writing original draft, data interpretation, writing original draft, supervising and revising. All authors reviewed the final manuscript. All authors have read and agreed to the published version of the manuscript.
FUNDING
Authors declare there was no extramural funding provided for this study.
CONFLICT OF INTEREST
The authors declare no conflict of interest in connection with the study.